Primary Angle-closure Glaucoma study: Kahook Dual Blade
Official title Kahook Dual Blade Goniotomy in Chronic Primary Angle-Closure Glaucoma
ClinicalTrials.gov ID: NCT07517302
What this study is testing
- What it's testing
- The study aims to find out if adding a Kahook Dual Blade tool to standard cataract surgery lowers eye pressure better than the standard surgery alone.
- Who it's for
- The study is looking for people who have both chronic angle-closure glaucoma and age-related cataracts.
- What's involved
- Participants will have cataract surgery to replace the cloudy lens. Some will also have a small tool used during the surgery to open the drainage angle of the eye.
- Time commitment
- The study lasts one year and requires follow-up visits to check eye pressure and safety.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- (1) age ≥ 40 years; (2) a confirmed diagnosis of CPACG, defined as the presence of peripheral anterior synechiae (PAS) extending ≥ 180° on...
You likely can't join if
- (1) any form of secondary angle-closure glaucoma (e.g., neovascular, uveitic, or lens-induced glaucoma)
The study team makes the final eligibility decision.
Where it is enrolling
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Beijing, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.